Changes in phytoplankton population along the saline gradient of the Júcar estuary and plume

This paper presents the results of phytoplankton counts carried out with epifluorescence at five sampling stations: two in the Júcar River Estuary and the other three in the region of freshwater influence of the Júcar River. From June 2002 to July 2003, nine sampling campaigns were carried out as a part of the EU's ECOSUD project. Two of these campaigns (the 2nd and 8th) were selected for analysis. These sampling campaigns represent two different conditions: in the 2nd campaign the discharge of the Júcar River was almost null, while in the 8th campaign it was significantly higher. Along the salinity gradient, as the influence of fresh water and nutrient loads decreases, a decrease in the population density of eukaryotic phytoplankton was observed. Typical freshwater phytoplankton groups (colonial cyanobacteria and chlorophyceae) clearly decrease in density and percentage as salinity increases. In general, picocyanobacteria exhibit the opposite behavior. The behavior pattern of groups with species adapted to fresh water and seawater is less clear. The density of these groups (diatoms and prymnesiophytes) is highest in the salt-wedge area due to nutrient accumulation. However, the densities are generally higher at the freshwater stations than in the marine environment. The vertical distribution at the estuarine stations shows clear density maximums in the interface area, which seems to have two causes: the retention of senescent phytoplankton affected by saline shock in this quiescent area and the growth of phytoplankton that exploit the accumulated nutrients.González Del Rio Rams, J.; Romero Gil, I.; Falco, S.; Rodilla, M.; Sierra, JP.; Sánchez-Arcilla, A.; Mösso, C. (2007). Changes in phytoplankton population along the saline gradient of the Júcar estuary and plume. Journal of Coastal Research. SI 47:63-68. doi:10.2112/1551-5036-47.sp1.63S6368SI 4

Neurobiologia do transtorno de humor bipolar e tomada de decisão na abordagem psicofarmacológica

O Transtorno do Humor Bipolar (THB) caracteriza-se por oscilações do humor que causam prejuízos significativos no âmbito biopsicossocial. O interesse da comunidade científica por este transtorno vem aumentando nos últimos cinco anos em função de sua crescente prevalência associada ao refinamento diagnóstico, à ampliação do arsenal terapêutico e ao conhecimento dos avanços nas pesquisas da neurobiologia do transtorno. A presente revisão aborda questões diagnosticas e terapêuticas aplicadas à neurobiologia dos THB, relacionando-as diretamente à terapêutica dos quadros de mania, hipomania, estados mistos, depressão bipolar e ciclagem rápida, da infância à idade adulta. São revisados criticamente importantes estudos realizados com diferentes fármacos potencialmente eficazes como estabilizadores do humor, nos diversos subdiagnósticos do THB. São analisados fármacos, tais como o lítio, anticonvulsivantes, antipsicóticos, benzodiazepínicos, bloqueadores dos canais de cálcio e hormônio tireoideo, bem como as possíveis bases biológicas para seus efeitos terapêuticos. Em síntese, este trabalho aborda os avanços da psicofarmacologia cuja eficácia é comprovada nos subtipos do THB, procurando relacioná-los com a neurobiologia deste transtorno.Bipolar Disorder (BD) is characterized by mood swings that cause significant impairment in social, occupational, or other areas of functioning. During the last years, new insights have been provided in the diagnosis, etiology, neurobiological basis and treatment of bipolar disorder. This paper emphasizes recent studies related to some diagnostic and therapeutic aspects during manic episode, hypomanic, mixed episode, bipolar depression and rapid cycling, in children, adolescents and adults. Studies using proposed mood stabilizers, which present adequate metodological basis, including double–blind, controlled studies and which presented a significant number of patients were included and critically evaluated in this revision. Drugs such as the lithium, anticonvulsants, antipsychotics, benzodiazepines, calcium channels blockers and thyroid augmentation are proposed to be effective in certain diagnostic profiles. The possible biological bases for these drugs therapeutic effects are also revised. In summary, this article focuses on recent and important psychopharmacological progresses on the treatment of BD subtypes. Furthermore, the revision presents possible biological basis to explain the therapeutic profile of these drugs